Number of items: 3.
Fiaschetti, G; Castelletti, D; Zoller, S; Schramm, A; Schroeder, C; Nagaishi, M; Stearns, D; Mittelbronn, M; Eggert, A; Westermann, F; Ohgaki, H; Shalaby, T; Pruschy, M; Arcaro, A; Grotzer, M A (2011). Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene, 30(25):2823-2835.
von Bueren, A O; Oehler, C; Shalaby, T; von Hoff, K; Pruschy, M; Seifert, Burkhardt; Gerber, N U; Warmuth-Metz, M; Stearns, D; Eberhart, C G; Kortmann, R D; Rutkowski, S; Grotzer, M A (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer, 11:74.
von Bueren, A O; Shalaby, T; Oehler-Jänne, C; Arnold, L; Stearns, D; Eberhart, C G; Arcaro, A; Pruschy, M; Grotzer, M A (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer, 9:10.
This list was generated on Sat Feb 23 04:30:52 2019 CET.